iSonea accelerates commercialisation of asthma devices in US, in negotiations … – Proactive Investors Australia

iSonea accelerates commercialisation of asthma devices in US, in negotiations
Proactive Investors Australia
They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is currently in negotiations with major strategic partners to accelerate commercialisation and cash flows of its next generation asthma products in

View full post on asthma – Google News